Clinical Trial: Acceptance and Committment Therapy Combined With Ketamine in Difficult-to-Treat Depression.

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906496) titled 'Acceptance and Committment Therapy Combined With Ketamine in Difficult-to-Treat Depression.' on Oct. 18.

Brief Summary: Ketamine is often used to treat depression where standard treatments have failed. Yet, even with ketamine, depression can persist and make it difficult to keep up with life. This study examines whether it is practical, safe and helpful to use a talk therapy (Acceptance and Commitment Therapy, ACT) in patients with difficult-to-treat depression receiving ketamine through the Ketamine Intervention Program at UBC Hospital. Researchers expect that combining ACT plus Ketamine ("K-ACT") will be feasible, safe, and will h...